Oxytocin Market Surges amid Rising Adoption across Postpartum Hemorrhage Surgeries: Future Market Insights Study

ESOMAR certified consulting firm Future Market Insights (FMI) has recently published an exhaustive yet unbiased report on the global oxytocin market, highlighting the prominent parameters responsible for steering growth in the long-run. The study opines global oxytocin sales to grow at over 8% through 2030, with growing focus on preventing PPH incidences expected to drive demand. ESOMAR certified consulting firm Future Market Insights (FMI) has recently published an exhaustive yet unbiased...

ESOMAR certified consulting firm Future Market Insights (FMI) has recently published an exhaustive yet unbiased report on the global oxytocin market, highlighting the prominent parameters responsible for steering growth in the long-run. The study opines global oxytocin sales to grow at over 8% through 2030, with growing focus on preventing PPH incidences expected to drive demand.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-11218

While the frequency of childbirths is increasing, the number of complications faced by women are also compounding. The Center for Disease Control and Prevention estimates that over 50,000 women across the U.S endure life-threatening complications.

Consequently, healthcare providers are incorporating solutions aimed at reducing trauma faced by patients which include numerous approaches. A common complication faced by women is postpartum hemorrhage, for which oxytocin treatment is a highly preferred option. A value CAGR exceeding 9% is projected for the market through 2030.  

Key Takeaways

 "Government initiatives to promote women and children's health are bolstering global efforts to improve maternity care across healthcare settings, thereby opening significant growth avenues for the global oxytocin market," comments the FMI analyst.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-11218

COVID-19 Impact Analysis

As the COVID-19 pandemic intensified, the global medical fraternity is facing immense challenges as resources are being redirected towards eradicating the deadly virus. Consequently, other treatment areas have been relegated to the backseat, including maternity care. This is a cause of concern amongst leading healthcare specialists.

Therefore, efforts are being made towards ensuring adequate and proper treatment to pregnant women across all regions. Furthermore, oxytocin has also been touted as an effective anti-viral agent, thus raising optimism that it could be effectively leveraged to promote drug or vaccine development.

The National Center for Biotechnology Information hypothesizes that oxytocin contains dipeptidyl peptidase-4 (DPP4) protease inhibitors could be effective against the existing novel coronavirus strain. It further propagates that enhancing endogenous oxytocin levels could increase viral resistance and improve health of vulnerable groups.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/11218

Competitive Landscape

Prominent players in the global oxytocin market include Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International Plc. (Par Sterile Products, LLC), Teva Pharmaceuticals Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd. and Yuhan Corporation.

The market is highly fragmented, peppered with numerous regional and global level market players. These players largely concentrate on forging strategic collaborations with existing players, regional distributors, product launches and acquisitions. Most players are concentrating on offering anesthetic oxytocin solutions to reduce labor induced complications for C-section operations.

Key Market Segments Covered in Oxytocin Industry Research

By Product:

By Distribution Channel:

We Offer tailor-made Solutions to fit Your Requirements, Request Customization - https://www.futuremarketinsights.com/customization-available/rep-gb-11218

Key Questions Answered in the Report

Top Reports Related To Healthcare Market Insights 

Dialyzer Reprocessing Machines and Concentrates Market: In 2022, the global dialyzer reprocessing machines and concentrates market is set to be worth US$ 1.2 Bn, and is predicted to attain a valuation of US$ 1.6 Bn by the end of 2028.

Multi-Parameter Patient Monitoring Market: The global multi-parameter patient monitoring market accounted for revenue worth US$ 4.6 Bn in 2022, and is projected to reach a valuation of US$ 6.1 Bn by 2028.

Seasonal Affective Disorder Therapeutics Market: Seasonal Affective Disorder Therapeutics Market By Treatment Type (Drugs, Devices), Disorder Type (Unipolar Disorders, Bipolar Disorders), Distribution Channel (Institutional Sales, Retail Sales) & Region - Forecast 2022 - 2028

About Future Market Insights (FMI) 

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. 

Contact: 

Future Market Insights, 
1602-6 Jumeirah Bay X2 Tower, 
Plot No: JLT-PH2-X2A, 
Jumeirah Lakes Towers, Dubai, 
United Arab Emirates 
For Sales Enquiries: [email protected] 
For Media Enquiries: [email protected] 
Website: https://www.futuremarketinsights.com/ 
Report: https://www.futuremarketinsights.com/reports/oxytocin-market 

Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg